                         SEQUENCE LISTING

<110>  The Methodist Hospital
       Vilentchouk, Biana G
       Srinivasan, Srimeenakshi
 
<120>  USE OF SOLUBLE CRKL COMPOSITIONS AS BREAST CANCER BIOMARKERS AND 
       PREDICTORS OF CANCER METASTASIS

<130>  37182-184WO01

<150>  US 62/150,150
<151>  2015-04-20

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  303
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ser Ser Ala Arg Phe Asp Ser Ser Asp Arg Ser Ala Trp Tyr Met 
1               5                   10                  15      


Gly Pro Val Ser Arg Gln Glu Ala Gln Thr Arg Leu Gln Gly Gln Arg 
            20                  25                  30          


His Gly Met Phe Leu Val Arg Asp Ser Ser Thr Cys Pro Gly Asp Tyr 
        35                  40                  45              


Val Leu Ser Val Ser Glu Asn Ser Arg Val Ser His Tyr Ile Ile Asn 
    50                  55                  60                  


Ser Leu Pro Asn Arg Arg Phe Lys Ile Gly Asp Gln Glu Phe Asp His 
65                  70                  75                  80  


Leu Pro Ala Leu Leu Glu Phe Tyr Lys Ile His Tyr Leu Asp Thr Thr 
                85                  90                  95      


Thr Leu Ile Glu Pro Ala Pro Arg Tyr Pro Ser Pro Pro Met Gly Ser 
            100                 105                 110         


Val Ser Ala Pro Asn Leu Pro Thr Ala Glu Asp Asn Leu Glu Tyr Val 
        115                 120                 125             


Arg Thr Leu Tyr Asp Phe Pro Gly Asn Asp Ala Glu Asp Leu Pro Phe 
    130                 135                 140                 


Lys Lys Gly Glu Ile Leu Val Ile Ile Glu Lys Pro Glu Glu Gln Trp 
145                 150                 155                 160 


Trp Ser Ala Arg Asn Lys Asp Gly Arg Val Gly Met Ile Pro Val Pro 
                165                 170                 175     


Tyr Val Glu Lys Leu Val Arg Ser Ser Pro His Gly Lys His Gly Asn 
            180                 185                 190         


Arg Asn Ser Asn Ser Tyr Gly Ile Pro Glu Pro Ala His Ala Tyr Ala 
        195                 200                 205             


Gln Pro Gln Thr Thr Thr Pro Leu Pro Ala Val Ser Gly Ser Pro Gly 
    210                 215                 220                 


Ala Ala Ile Thr Pro Leu Pro Ser Thr Gln Asn Gly Pro Val Phe Ala 
225                 230                 235                 240 


Lys Ala Ile Gln Lys Arg Val Pro Cys Ala Tyr Asp Lys Thr Ala Leu 
                245                 250                 255     


Ala Leu Glu Val Gly Asp Ile Val Lys Val Thr Arg Met Asn Ile Asn 
            260                 265                 270         


Gly Gln Trp Glu Gly Glu Val Asn Gly Arg Lys Gly Leu Phe Pro Phe 
        275                 280                 285             


Thr His Val Lys Ile Phe Asp Pro Gln Asn Pro Asp Glu Asn Glu 
    290                 295                 300             


